Citation Impact
Citing Papers
Patterns of mortality after prolonged follow-up of a randomised controlled trial using granulocyte colony-stimulating factor to maintain chemotherapy dose intensity in non-Hodgkin's lymphoma
2008
Myeloproliferative disorders: complications, survival and causes of death
2000
Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party, Cambridge, United Kingdom.
1998
Increased Thrombopoiesis and Platelet Activation in Hantavirus-Infected Patients
2015 StandoutNobel
ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology
2006 Standout
Is Caregiving Hazardous to One's Physical Health? A Meta-Analysis.
2003 Standout
Placebo-Controlled phase III Study of lenograstim (Glycosylated recombinant human granulocyte colony-Stimulating factor) in Aggressive non-Hodgkin's lymphoma: Factors influencing chemotherapy administration
1997
Contribution of platelets to tumour metastasis
2011 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
2012 Standout
Severe and complicated malaria
1990 Standout
Molecular Mechanisms of Human Hypertension
2001 Standout
MONOCLONAL GAMMOPATHIES OF UNDETERMINED SIGNIFICANCE
1999
Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.
1996
Plasmodium Falciparum: Effect of Infected Erythrocytes on Clotting Time of Plasma
1987
Serum TSH, T4, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)
2002 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
2014 Standout
Hematopoietic growth factors in cancer patients with invasive fungal infections
1997
Genetic Susceptibility for Human Familial Essential Hypertension in a Region of Homology with Blood Pressure Linkage on Rat Chromosome 10
1997 StandoutNobel
Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases
2005
Streptococcus pneumoniae Bacteremia in Patients With Cancer
2005
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Botanical polysaccharides: Macrophage immunomodulation and therapeutic potential
2005 Standout
The predictive value of body protein for chemotherapy-induced toxicity
2000
Amino acids and immune function
2007 Standout
Monoclonal Gammopathy of Undetermined Significance
2005
A Comparative Review of Colony-Stimulating Factors
1997
The colony-stimulating factors and cancer
2010
Neutrophils in cancer: neutral no more
2016 Standout
CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial
2003
Prophylactic colony-stimulating factors in children receiving myelosuppressive chemotherapy: A meta-analysis of randomized controlled trials
2006
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia.
1996
Human hypertension caused by mutations in the kidney isozyme of 11β–hydroxysteroid dehydrogenase
1995
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
The Potential Role of Cytokine Therapy for Fungal Infections in Patients with Cancer: Is Recovery from Neutropenia all that is Needed?
1998
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
2008 Standout
Elevation of serum thrombopoietin precedes thrombocytosis in acute infections
2002
Are prophylactic haematopoietic growth factors of value in the management of patients with aggressive non-Hodgkin's lymphoma?
2004
Cytokines as therapy for opportunistic fungal infections
1998
A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care
2008 Standout
PRODUCTION AND ROLE OF INTERFERON IN PHYSIOLOGICAL CONDITIONS
1981
Meta-analysis: Effect of Prophylactic Hematopoietic Colony-Stimulating Factors on Mortality and Outcomes of Infection
2007
Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
2009 Standout
Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
2002 Standout
Activation of B lymphocytes by locally concentrated concanavalin A
1972 StandoutNobel
G-CSF and GM-CSF in Neutropenia
2015
CLASSIFICATION OF NON-HODGKIN'S LYMPHOMAS
1974
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Acetylcholine-Synthesizing T Cells Relay Neural Signals in a Vagus Nerve Circuit
2011 StandoutScience
Attempts to demonstrate virus‐specific sequences in human tumors. IV. EB viral DNA in European burkitt lymphoma and immunoblastic lymphadenopathy with excessive plasmacytosis
1976 StandoutNobel
PROMOTION OF REPLICATION IN LYMPHOID CELLS BY SPECIFIC THIOLS AND DISULFIDES IN VITRO
1973
Impact of pretreatment thrombocytosis on survival in primary breast cancer
2003
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Leukocytic proteases and the immunologic release of lysosomal enzymes.
1972
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Pneumocystis cariniiPneumonia and Mucosal Candidiasis in Previously Healthy Homosexual Men
1981 Standout
Hormonal Control of Lysosomal Enzyme Release from Human Neutrophils: Elevation of Cyclic Nucleotide Levels by Autonomic Neurohormones
1974 StandoutNobel
Aspergillus fumigatusand Aspergillosis
1999 Standout
Thymidine kinase, deoxycytidine kinase and deoxycytidylate deaminase activities in phytohaemagglutinin stimulated human lymphocytes
1971
Gene Targeting Approaches to Analyzing Hypertension
1999 StandoutNobel
Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo.
2001
Randomized, Multicenter, Open-Label Study of Pegfilgrastim Compared With Daily Filgrastim After Chemotherapy for Lymphoma
2003
Lymphocyte activation. I. Response of T and B lymphocytes to phytomitogens.
1971
The Impact of Aging on Adrenergic Receptor Function: Clinical and Biochemical Aspects
1985 StandoutNobel
Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple
2001 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Protein synthesis in stimulated lymphocytes
1975
HORMONAL CONTROL OF LYSOSOMAL ENZYME RELEASE FROM HUMAN NEUTROPHILS
1974 StandoutNobel
In vitro transformation of lymphoid cells by Abelson murine leukemia virus.
1975 StandoutNobel
Interaction of Polymorphonuclear Neutrophils with Escherichia Coli
1978 StandoutNobel
Thrombocytosis: Diagnostic Evaluation, Thrombotic Risk Stratification, and Risk-Based Management Strategies
2011
Population immunology: Age and immune cell parameters
1978
Reduced β-adrenergic receptor concentrations in ageing man
1977 Nature
Protein kinase in human plasma analogous to that present in control and interferon-treated HeLa cells
1981 StandoutNobel
FIBRIN-DEGRADATION PRODUCTS IN CEREBRAL MALARIA
1972
Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma
2008
ImmunologicalStatus of aged subjects with reference to serological evidence of autoimmunity
1977
Adenosine kinase from rabbit liver. II. Substrate and inhibitor specificity
1979 StandoutNobel
Works of G. Brittinger being referenced
Frequent association of idiopathic myelofibrosis with plasma cell dyscrasias
1988
Differential Effect of the Activation of Protein Kinase A on the Protein Synthesis and Secretion in the T‐Helper 2 Cell Line D10.G4.1
1996
Thrombopoietin serum concentration in patients with reactive and myeloproliferative thrombocytosis
1998
Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas [see comments]
1993
DECREASE OF T LYMPHOCYTES DURING AGEING
1974
Cerebral malaria and intravascular coagulation.
1970
Template Activity of Nuclei from Stimulated Lymphocytes
1969 Nature
[Lysosomal enzymes in blood lymphocytes of normal subjects and patients with chronic lymphadenosis after nonspecific stimulation in vitro of short duration].
1970
Relation of Lysosomal Fragility in CLL Lymphocytes to PHA Reactivity
1973
LYMPHOCYTE POPULATIONS IN CHRONIC LYMPHOCYTIC LEUKÆMIA
1973
Lysosomale Enzyme in Lymphozyten
1970
Antibody responses of splenectomized patients with non-Hodgkin's lymphoma to immunization with polyvalent pneumococcal vaccines
1997
NORMAL RECIRCULATION OF T LYMPHOCYTES IN CHRONIC LYMPHOCYTIC LEUKÆMIA
1975